MLTX
MoonLake Immunotherapeutics
10.60$
-1.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 97.7% | 98.1% | 98.5% | 98.9% | 99.2% | 99.0% | 99.0% | 99.2% | 99.4% | 99.1% | 99.3% | |
| 63.6% | 85.7% | 81.3% | 62.9% | 72.5% | 37.8% | 53.1% | 66.7% | 84.7% | 78.8% | 74.6% | 83.3% | |
| 99.2% | 97.1% | 97.0% | 95.4% | 95.3% | 93.7% | 93.9% | 92.4% | 91.8% | 92.8% | 89.4% | 93.6% | |
| 0.1% | 0.2% | 0.3% | 0.3% | 0.5% | 0.6% | 0.6% | 0.7% | 1.0% | 1.1% | 1.4% | 1.1% | |
| 2.1% | 2.5% | 2.1% | 2.7% | 4.4% | 5.1% | 19.3% | 22.2% | 29.7% | 28.3% | 36.6% | 25.4% | |
| 2.1% | 1.9% | 1.6% | 2.3% | 3.9% | 4.7% | 4.7% | 5.9% | 11.7% | 10.7% | 11.5% | 7.9% | |
| 0.0% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.3% | 0.2% | 0.2% | |
| 0.2% | 0.3% | 0.5% | 0.9% | 2.0% | 1.8% | 2.0% | 3.2% | 5.7% | 6.7% | 5.8% | 3.0% | |
| – | – | – | – | – | – | 14.3% | 15.9% | 17.8% | 17.5% | 24.7% | 17.3% | |
| 84.9% | 94.1% | 96.2% | 95.6% | 94.2% | 93.5% | 79.7% | 76.9% | 69.7% | 71.7% | 63.4% | 74.6% | |
| -21.8% | -22.2% | -23.1% | -28.4% | -36.7% | -49.3% | -53.9% | -71.9% | -96.7% | -109.1% | -133.0% | -103.6% | |
| 10.7% | 11.4% | 11.1% | 11.5% | 12.1% | 13.2% | 12.4% | 13.8% | 15.3% | 15.2% | 17.8% | 12.9% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.